Project Partners

Fondazione IRCCS Istituto Nazionale dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori (INT) is a leading national and international cancer treatment and research centre.  

The Institute addresses clinical challenges across all cancer stages, focusing on: prevention and prediction, diagnosis and treatment (surgery, medicine,radiotherapy), rehabilitation and psychological support, pain management and palliative care. Its mission combines delivering current treatments with pioneering new ones through preclinical, clinical, and data science research, rapid translation of discoveries into improved patient care and quality of life. 

The INT project team includes Dr. Maria Carmen De Santis, Carlotta Giandini, and Maria Grazia Carnevale, radiation oncologists from the Diagnostic Imaging and Radiotherapy, Radiation Oncology Unit; Alessandro Cicchetti, Luca Possenti, Eliana Gioscio, Jacopo Jacovacci, Benedetta Dionisi Ferrera, Francesco Pisani, as multidisciplinary research team, and is supported by Clara Marrone, Daniela Bavuso, and Tania Sanna as coordination team from the Data Science Unit, CMON Lab. 

Under Tiziana Rancati’s leadership as Project Investigator, INT is responsible for Work Package 1 – Coordination and Project Management, which ensures the timely and high-quality delivery of project results through technical, organisational, and financial coordination. WP1 guarantees that project agreements and objectives are correctly implemented, while also overseeing the management of data and knowledge generated throughout the project.  

INT also leads Work Package 9 – Prospective Collection, which establishes a standardised prospective dataset of breast cancer patients receiving radiotherapy after conservative surgery in clinical centres across the TETRIS Consortium. The protocol for the TETRIS prospective observational study.reflects the project’s core vision: integrating biological, clinical, imaging, and behavioral data to improve and enhance digital twins for breast cancer radiotherapy. This new data will support the development of detailed digital twins for radiation safety applications.

In addition, INT coordinates Work Package 10 – Dissemination and Exploitation, which focuses on communicating and promoting project activities and outcomes through targeted dissemination, exploitation, and communication actions addressed to relevant stakeholders : scientific/clinical, industry, regulatory/policy, patient/civil society, and the general public. It also creates synergies with ongoing initiatives and related projects.  

Follow Us

@projectetris
📢 TETRIS Educational Series | New Date Confirmed

We are pleased to confirm that the third webinar of the TETRIS Educational Series has been rescheduled and will now take place on:
🗓 23 April 2026
 ⏰ 13:00–14:00 CET

The session will be presented by Ana Vega and Miguel Elías Aguado-Barrera from Fundación Pública Galega de Medicina Xenómica (FPGMX) and will explore the role of transcriptomics in advancing personalised risk assessment and improving the safety of radiotherapy treatments.

🔓 The webinar is open to everyone.
👉 To join the session, click here: urlr.me/MaBKQ4. 
We look forward to welcoming you!

#TETRISproject #Education #Radiotherapy #Transcriptomics #Webinar #CancerResearch #DigitalTwins #HorizonEurope

...

3 0
‼️ Postponed: 3rd Webinar, TETRIS Educational Series, 

Due to an unexpected scheduling issue, the third webinar of the TETRIS Educational Series, Transcriptomic Risk Score Development for Risk Modelling: The TETRIS WP5 Framework, originally planned for 26 March 2026, will need to be rescheduled. 

📅 The new date will be communicated soon.

We sincerely apologise for the short notice, we understand this may be inconvenient and truly appreciate your understanding.

Stay tuned for updates!

...

1 0
📢 Have you already added the 3rd TETRIS webinar to your agenda?

Join us for the third webinar of the TETRIS Educational Series, taking place on:

🗓 Thursday, 26 March 2026
⏰ 13:00–14:00 CET

The session will be presented by Ana Vega and Miguel Elías A. from Fundación Pública Galega de Medicina Xenómica (FPGMX).

The webinar will explore how transcriptomics can support personalised risk assessment and contribute to improving the safety of radiotherapy treatments within the TETRIS project.

🔓 The webinar is open to everyone.
👉 To join the session, click here: urlr.me/MaBKQ4. 

We look forward to welcoming you to the third appointment of the TETRIS Educational Series!

...

1 0